Choosing a cancer therapy is too important to leave to trial and error

Nov 3 2011 3:35 PM

Every person’s cancer is different. Oncology treatment has often had to rely on a trial-and-error approach to identifying and selecting treatments. The right cancer treatment can extend a cancer patient's life as well as improve their quality of life.

As every tumor is different, two patients with the same cancer may respond very differently to the exact same treatment. Even the world's best doctors cannot know in advance how a tumor will respond to a particular treatment.

Cancer therapies vary in their effectiveness and in most instances, standard non-personalized treatment regimens are unsuccessful in a majority of patients  And for some cancers, it is even lower.

Your cancer deserves an individual approach.

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.